Induced Suppression of Platelets Activity in Aneurysmal SAH Management (iSPASM)

NCT03691727 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Subarachnoid Hemorrhage, Aneurysmal

Interventions

DRUG: tirofiban hydrochloride (AGGRASTAT®)
DIAGNOSTIC_TEST: MRI
DIAGNOSTIC_TEST: Neurological Exam
BEHAVIORAL: Questionnaires
DIAGNOSTIC_TEST: Vital Signs
OTHER: Standard of Care Treatment

Sponsor

David Hasan